MedTrace Logo

Effect of Infant Formula on Energy Balance

NCT01700205 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 113

Last updated 2019-11-22

Study results available
· View outcomes & findings →

Summary

The overarching goal of the research we propose here is to conduct a randomized clinical trial to specify the physiologic and behavioral mechanisms by which infant-formula composition affects all aspects of energy balance and growth during the first years of life.

Conditions

  • Development

Interventions

OTHER

Type of Formula

infant formula

Sponsors & Collaborators

  • University of Delaware

    collaborator OTHER

  • Children's Hospital of Philadelphia

    collaborator OTHER

  • University of Wisconsin, Madison

    collaborator OTHER

  • Monell Chemical Senses Center

    lead OTHER

Principal Investigators

  • Julie A Mennella, PhD · Monell Chemical Senses Center

  • Jillian Trabulsi, PhD · University of Delaware

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
1 Week
Max Age
3 Weeks
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-11-02
Primary Completion
2016-03-17
Completion
2016-09-21

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01700205 on ClinicalTrials.gov